Trials / Completed
CompletedNCT01272102
Macular Ganglion Cell Analysis (GCA) of the Cirrus HD-OCT in Glaucoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 119 (actual)
- Sponsor
- Carl Zeiss Meditec, Inc. · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
To determine the area under the Receiver Operator Characteristic Curve (AUC) for the Ganglion Cell Analysis (GCA) average thickness.
Detailed description
To determine the area under the Receiver Operator Characteristic Curve (AUC) for the following GCA parameters: 1. Minimum thickness 2. Supero-temporal thickness 3. Superior thickness 4. Supero-nasal thickness 5. Infero-temporal thickness 6. Inferior thickness 7. Infero-nasal thickness
Conditions
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2011-01-07
- Last updated
- 2013-06-25
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01272102. Inclusion in this directory is not an endorsement.